In 2025, the Center for Gene Therapy transitioned to the Precision Medicine Center for Cystic Fibrosis, reflecting our commitment to personalized treatments for CF. This new name highlights our focus on cutting-edge research, tailored therapies, and improving patient outcomes. Stay connected as we continue to lead the way in precision medicine for cystic fibrosis!
Precision Medicine Center for Cystic Fibrosis
The goal of PRECISION MEDICINE CENTER FOR CYSTIC FIBROSIS is to provide a forum for uniting scientists involved in diverse but relevant research fields, enabling them to focus on issues central to the development of molecular therapies for cystic fibrosis (CF). Our aim is to use the resources available from this Center to provide a fertile environment for the exchange of ideas, the sharing of expertise, and the co-mentoring of junior investigators in establishing independent CF-focused research programs, in order to promote and increase the pace of progress in developing molecular therapies for CF.
Madison O'Leary
The Administrative Core, consisting of the Center Director Amy Ryan, and an Administrator Madison O'Leary. This Core coordinates and oversees many different aspects of the Center, including financial documentation, accountability, membership and recruitment, scientific enrichment programs such as external speaker seminars and a weekly CF Research Seminar series, retreats, workshops, recruitment and external reviews of pilot and feasibility applications, review of the Research Cores.